U.S. Markets open in 1 hr 45 mins

Protagonist Therapeutics, Inc. (PTGX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
31.81-2.46 (-7.18%)
At close: 04:00PM EST
31.81 0.00 (0.00%)
After hours: 04:01PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close34.27
Bid0.00 x 900
Ask0.00 x 800
Day's Range31.63 - 35.54
52 Week Range12.80 - 50.54
Avg. Volume585,070
Market Cap1.518B
Beta (5Y Monthly)2.17
PE Ratio (TTM)N/A
EPS (TTM)-2.43
Earnings DateMar 08, 2022 - Mar 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est53.88

    5 Biotech Stocks That Are Bucking the Selloff

    Biotech investors still like BioCryst, Protagonist, Prometheus Biosciences, Rani, and Emergent BioSolutions. All sported recent double-digit gains despite the sector slump.

  • Insider Monkey

    Protagonist Therapeutics, Inc. (PTGX) Fell Out Of Favor With Hedge Funds

    In this article we will check out the progression of hedge fund sentiment towards Protagonist Therapeutics, Inc. (NASDAQ:PTGX) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and […]

  • PR Newswire

    /C O R R E C T I O N -- Protagonist Therapeutics, Inc./

    Protagonist Therapeutics (Nasdaq: PTGX) ("Protagonist" or "the Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11 at 2:15 p.m. EST.